Literature DB >> 23205129

Sphere-forming tumor cells possess stem-like properties in human fibrosarcoma primary tumors and cell lines.

Wei-Dong Liu1, Tao Zhang, Chun-Lei Wang, Hong-Mei Meng, Yu-Wen Song, Zhe Zhao, Zheng-Min Li, Jiang-Kun Liu, Shang-Ha Pan, Wen-Bo Wang.   

Abstract

Fibrosarcoma is a malignant soft tissue tumor of mesenchymal origin. Despite advances in medical and surgical treatment, patient survival rates have remained poor. According to the cancer stem cell hypothesis, tumors are comprised of heterogeneous cell populations that have different roles in tumor formation and growth. Cancer stem cells are a small cell subpopulation that exhibits stem-like properties to gain aggressiveness and recurrence. These cells have been identified in a variety of cancerous tumors, but not in human fibrosarcoma. In this study, we observed that HT1080 cells and primary fibrosarcoma cells formed spheres and showed higher self-renewal capacity, invasiveness and drug resistance compared with their adherent counterparts. Moreover, we demonstrated that the cells showed higher expression of the embryonic stem cell-related genes Nanog, Oct3/4, Sox2, Sox10 and their encoding proteins, as well as greater tumorigenic capacity in nude mice. In conclusion, our data suggest the presence of a stem-like cell population in human fibrosarcoma tumors, which provides more evidence for the cancer stem cell hypothesis and assistance in designing new therapeutic strategies against human fibrosarcoma.

Entities:  

Year:  2012        PMID: 23205129      PMCID: PMC3506720          DOI: 10.3892/ol.2012.940

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors:  C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

Review 4.  Cancer stem cells: how can we target them?

Authors:  Ivan Ischenko; Hendrik Seeliger; Moshe Schaffer; Karl-Walter Jauch; Christiane J Bruns
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

6.  Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes.

Authors:  Radhika R Pochampally; Jason R Smith; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 7.  Cancer stem cell: target for anti-cancer therapy.

Authors:  Carol Tang; Beng T Ang; Shazib Pervaiz
Journal:  FASEB J       Date:  2007-07-11       Impact factor: 5.191

8.  Bone cancers.

Authors:  H D Dorfman; B Czerniak
Journal:  Cancer       Date:  1995-01-01       Impact factor: 6.860

9.  Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.

Authors:  Chao Chen; Yan Wei; Michael Hummel; Thomas K Hoffmann; Manfred Gross; Andreas M Kaufmann; Andreas E Albers
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Targeting the osteosarcoma cancer stem cell.

Authors:  Valerie A Siclari; Ling Qin
Journal:  J Orthop Surg Res       Date:  2010-10-27       Impact factor: 2.359

View more
  12 in total

1.  Tissue necrosis and its role in cancer progression.

Authors:  Adi Karsch-Bluman; Ariel Feiglin; Eliran Arbib; Tal Stern; Hila Shoval; Ouri Schwob; Michael Berger; Ofra Benny
Journal:  Oncogene       Date:  2018-11-02       Impact factor: 9.867

2.  Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.

Authors:  Ekaterina Schreiber-Brynzak; Erik Klapproth; Christine Unger; Irene Lichtscheidl-Schultz; Simone Göschl; Sarah Schweighofer; Robert Trondl; Helmut Dolznig; Michael A Jakupec; Bernhard K Keppler
Journal:  Invest New Drugs       Date:  2015-06-21       Impact factor: 3.850

3.  In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.

Authors:  Ignacio E León; Juan F Cadavid-Vargas; Agustina Resasco; Fabricio Maschi; Miguel A Ayala; Cecilia Carbone; Susana B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2016-10-01       Impact factor: 3.358

4.  Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.

Authors:  Banu Iskender; Kenan Izgi; Halit Karaca; Halit Canatan
Journal:  J Nat Med       Date:  2015-06-09       Impact factor: 2.343

5.  B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor.

Authors:  Yupeng Yang; K E Wu; Ende Zhao; Wei Li; Liang Shi; Gengchen Xie; Bin Jiang; Yaxin Wang; Ruidong Li; Peng Zhang; Xiaoming Shuai; Guobin Wang; Kaixiong Tao
Journal:  Oncol Lett       Date:  2015-02-10       Impact factor: 2.967

6.  Human lung-derived mesenchymal stem cell-conditioned medium exerts in vitro antitumor effects in malignant pleural mesothelioma cell lines.

Authors:  Lourdes Cortes-Dericks; Laurene Froment; Gregor Kocher; Ralph A Schmid
Journal:  Stem Cell Res Ther       Date:  2016-02-09       Impact factor: 6.832

Review 7.  Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies.

Authors:  Daniela Augsburger; Peter J Nelson; Thomas Kalinski; Andrej Udelnow; Thomas Knösel; Monika Hofstetter; Ji Wei Qin; Yan Wang; Arvid Sen Gupta; Susanne Bonifatius; Minglun Li; Christiane J Bruns; Yue Zhao
Journal:  Oncotarget       Date:  2017-08-10

8.  Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model.

Authors:  Michaela Kripnerová; Hamendra Singh Parmar; Jiří Šána; Alena Kopková; Lenka Radová; Sieghart Sopper; Krzysztof Biernacki; Jan Jedlička; Michaela Kohoutová; Jitka Kuncová; Jan Peychl; Emil Rudolf; Miroslav Červinka; Zbyněk Houdek; Pavel Dvořák; Kateřina Houfková; Martin Pešta; Zdeněk Tůma; Martina Dolejšová; Filip Tichánek; Václav Babuška; Martin Leba; Ondřej Slabý; Jiří Hatina
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

9.  MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.

Authors:  Bin Qiao; Jing-Hua Cai; Alfred King-Yin Lam; Bao-Xia He
Journal:  Oncotarget       Date:  2017-08-07

10.  Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.

Authors:  Amnani Aminuddin; Pei Yuen Ng; Chee-Onn Leong; Eng Wee Chua
Journal:  Sci Rep       Date:  2020-05-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.